Lobaplatin Enhances Radioactive

AKT/mTOR pathway apoptosis lobaplatin non-small cell lung cancer proliferation radioactive 125I seed

Journal

OncoTargets and therapy
ISSN: 1178-6930
Titre abrégé: Onco Targets Ther
Pays: New Zealand
ID NLM: 101514322

Informations de publication

Date de publication:
2021
Historique:
received: 21 10 2020
accepted: 25 12 2020
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 21 1 2021
Statut: epublish

Résumé

In recent years, radioactive In this study, we investigated the apoptosis and anti-proliferative effect induced by Based on our results, the sensitizing concentration of LBP could enhance the Our study proved that LBP promotes the apoptotic and anti-proliferative effects of

Identifiants

pubmed: 33469307
doi: 10.2147/OTT.S288012
pii: 288012
pmc: PMC7811486
doi:

Types de publication

Journal Article

Langues

eng

Pagination

289-300

Informations de copyright

© 2021 Rong et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest for this work.

Références

Biomed Pharmacother. 2020 Jun;126:110066
pubmed: 32172065
Br J Cancer. 2006 Jun 5;94(11):1678-82
pubmed: 16721365
Brachytherapy. 2018 Mar - Apr;17(2):439-448
pubmed: 29275079
Asian Pac J Cancer Prev. 2015;16(9):4003-6
pubmed: 25987076
Curr Pharm Des. 2013;19(30):5333-43
pubmed: 23394083
J Clin Oncol. 2016 Nov 1;34(31):3803-3815
pubmed: 27621407
Onco Targets Ther. 2020 Mar 04;13:1909-1919
pubmed: 32184626
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):717
pubmed: 32180459
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Oncol Lett. 2018 Nov;16(5):5969-5977
pubmed: 30344747
Int J Cancer. 2014 Sep 15;135(6):1417-24
pubmed: 24523200
J Cancer Res Ther. 2018;14(7):1476-1481
pubmed: 30589026
Cell Death Dis. 2019 Oct 3;10(10):744
pubmed: 31582720
Front Oncol. 2019 Jul 24;9:538
pubmed: 31428569
Radiology. 1987 Sep;164(3):735-40
pubmed: 3615870
Oncol Rep. 2019 Mar;41(3):1875-1882
pubmed: 30628719
N Engl J Med. 2017 Aug 31;377(9):849-861
pubmed: 28854088
Nat Rev Cancer. 2018 Dec;18(12):744-757
pubmed: 30425336
Biomed Pharmacother. 2015 Feb;69:402-8
pubmed: 25661389
Anticancer Drugs. 2012 Aug;23(7):698-705
pubmed: 22441567
Int J Mol Sci. 2020 May 06;21(9):
pubmed: 32384682
Nat Med. 2004 Jun;10(6):594-601
pubmed: 15156201
Clin Chest Med. 2011 Dec;32(4):703-40
pubmed: 22054881
BMC Pulm Med. 2019 Nov 8;19(1):205
pubmed: 31703663
Oncol Lett. 2018 May;15(5):6211-6216
pubmed: 29616103
J Oncol. 2019 Dec 20;2019:5956867
pubmed: 31929797
Oncol Rep. 2018 Mar;39(3):1523-1531
pubmed: 29328421
Cancers (Basel). 2019 Feb 22;11(2):
pubmed: 30813295

Auteurs

Jia-Hui Rong (JH)

Department of Cardiology, The Second Hospital of Shandong University, Jinan, People's Republic of China.

Dong Li (D)

Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, People's Republic of China.

Yu-Liang Li (YL)

Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, People's Republic of China.

Classifications MeSH